A diabetes pill developed by Bristol-Myers (BMY) and AstraZeneca (AZN) was effective in a Phase III study, although the trial produced increased cases of bladder and breast cancers. The drug, dapagliflozin, is set to be reviewed by an FDA advisory committee in July.
Are you Bullish or Bearish on ?
Sentiment on ()
Thanks for sharing your thoughts.